Planned Parenthood of New York City & Emergency Contraception

Planned Parenthood of New York City (PPNYC) tasked the Capstone team with forecasting the impact to the organization when emergency contraception (EC), now available only by prescription, becomes an over-the-counter (OTC) drug. The specific objective of this project is to assess the impact on PPNYC’s revenue, patient volume, and number and type of services when PPNYC and its competitors offer ECover-the-counter, and to make recommendations on maintaining revenue. Currently, patients who come to PPNYC for EC are encouraged to make a follow-up appointment and are offered a variety of services. However, if the number of initial EC visits declines, PPNYC is facing both a loss of patients as well as a revenue loss. If PPNYC does lose patients because EC is offered OTC, then PPNYC needs to find away to “get people in the door.” The Capstone team found that although visits to obtain a prescription for EC currently provide PPNYC with a significant source of revenue, PPNYC has several options in distributing EC when it becomes OTC that will preserve a stream of new patients and revenue.
 

This Capstone was made possible with support from an anonymous donor through FJC: A Donor-Advised Fund.